439 related articles for article (PubMed ID: 26856794)
21. Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells.
Qu D; Johnson J; Chandrakesan P; Weygant N; May R; Aiello N; Rhim A; Zhao L; Zheng W; Lightfoot S; Pant S; Irvan J; Postier R; Hocker J; Hanas JS; Ali N; Sureban SM; An G; Schlosser MJ; Stanger B; Houchen CW
PLoS One; 2015; 10(2):e0118933. PubMed ID: 25723399
[TBL] [Abstract][Full Text] [Related]
22. Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Berger AW; Schwerdel D; Costa IG; Hackert T; Strobel O; Lam S; Barth TF; Schröppel B; Meining A; Büchler MW; Zenke M; Hermann PC; Seufferlein T; Kleger A
Gastroenterology; 2016 Aug; 151(2):267-70. PubMed ID: 27343369
[TBL] [Abstract][Full Text] [Related]
23. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review.
Abdallah R; Taly V; Zhao S; Pietrasz D; Bachet JB; Basile D; Mas L; Zaanan A; Laurent-Puig P; Taieb J
Cancer Treat Rev; 2020 Jul; 87():102028. PubMed ID: 32485509
[TBL] [Abstract][Full Text] [Related]
24. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.
Gao Y; Zhu Y; Yuan Z
Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.
Hadano N; Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Sueda T; Hiyama E
Br J Cancer; 2016 Jun; 115(1):59-65. PubMed ID: 27280632
[TBL] [Abstract][Full Text] [Related]
26. Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells.
Dimitrov-Markov S; Perales-Patón J; Bockorny B; Dopazo A; Muñoz M; Baños N; Bonilla V; Menendez C; Duran Y; Huang L; Perea S; Muthuswamy SK; Al-Shahrour F; Lopez-Casas PP; Hidalgo M
Mol Cancer Ther; 2020 Aug; 19(8):1751-1760. PubMed ID: 32499301
[TBL] [Abstract][Full Text] [Related]
27. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers.
Kaczor-Urbanowicz KE; Cheng J; King JC; Sedarat A; Pandol SJ; Farrell JJ; Wong DTW; Kim Y
Pancreas; 2020 Oct; 49(9):1141-1152. PubMed ID: 33003085
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
[TBL] [Abstract][Full Text] [Related]
29. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
Sun B; Liu X; Gao Y; Li L; Dong Z
Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
[TBL] [Abstract][Full Text] [Related]
31. Portal-vein blood samples as a new diagnostic entity for pancreatic cancer.
Chapman CG; Waxman I
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):665-7. PubMed ID: 27077275
[No Abstract] [Full Text] [Related]
32. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
33. Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma - Mini-Review.
Liberko M; Kolostova K; Szabo A; Gurlich R; Oliverius M; Soumarova R
In Vivo; 2021; 35(1):31-39. PubMed ID: 33402447
[TBL] [Abstract][Full Text] [Related]
34. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.
Sugimori M; Sugimori K; Tsuchiya H; Suzuki Y; Tsuyuki S; Kaneta Y; Hirotani A; Sanga K; Tozuka Y; Komiyama S; Sato T; Tezuka S; Goda Y; Irie K; Miwa H; Miura Y; Ishii T; Kaneko T; Nagahama M; Shibata W; Nozaki A; Maeda S
Cancer Sci; 2020 Jan; 111(1):266-278. PubMed ID: 31746520
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma.
Park Y; Jun HR; Choi HW; Hwang DW; Lee JH; Song KB; Lee W; Kwon J; Ha SH; Jun E; Kim SC
Sci Rep; 2021 Jan; 11(1):1644. PubMed ID: 33462311
[TBL] [Abstract][Full Text] [Related]
36. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
37. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
[TBL] [Abstract][Full Text] [Related]
38. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
[TBL] [Abstract][Full Text] [Related]
39. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.
Arnoletti JP; Zhu X; Almodovar AJ; Veldhuis PP; Sause R; Griffith E; Corpus G; Chang JC; Fanaian N; Litherland SA
Pancreas; 2017 Jan; 46(1):116-123. PubMed ID: 27400259
[TBL] [Abstract][Full Text] [Related]
40. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
